The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1372
ISSUE1372
September 5, 2011
Ticagrelor (Brilinta) - Better than Clopidogrel (Plavix)?
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Ticagrelor (Brilinta) - Better than Clopidogrel (Plavix)?
September 5, 2011 (Issue: 1372)
The FDA has approved ticagrelor (Brilinta –
AstraZeneca), an oral antiplatelet drug, for use with
low-dose aspirin to reduce the rate of thrombotic cardiovascular
events in patients with acute coronary syndrome
(ACS). It will compete with...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.